CAMELOT FANTASIES

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Closes 2016 On A Higher Note
share on:FacebookTwitter


As 2016 closed in, OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) remained one of the upward trending stocks in the cannabis industry. The company, in the last quarter of 2016, announced signing an agreement with Medmar LLC in a deal that was worth $300,000. Now let us understand what makes OWC Pharmaceutical Research so favoured in the cannabis industry?
The medical research that is worth the partnerships
This company, which is primarily Israeli-based, comes to the U.S. market with much credibility. Israel, for we all know, is among those countries, which offers the best research and clinical trials for cannabis based medicines. OWC Pharmaceutical Research is a favoured company for partnership due to this ground.
It is believed that the company is reputed for conducting clinical approaches and R&D for medical cannabis in the true sense. The clinical studies conducted by this company have much value in the cannabis market. To make an investment and partnership with this company comes with its own advantages.
Why everyone wants to befriend OWC Pharmaceutical Research?
Even though the U.S. regulations are difficult to cope with, but there is no denying the fact that the times ahead may be favourable. As of now, any wannabe cannabis company that is looking forward to these times in the U.S. market, need to know that OWC Pharmaceutical Research is definitely in a better position because the environment for cannabis industry in Israel is much more favourable.
This company has continued to ride the higher tide of the cannabis market because it is conducting research in a holistic environment that guarantees clinical research with lesser hurdles. Who knows what happens in the U.S. next, but for now, there is definitely a hope like a shining moonbeam. The new Presidency era in the U.S. will open up new avenues and hopes for the cannabis industry, which is why, so many companies, which remained dormant as of now, have started picking up the momentum in markets.